This inventor holds 1 USPTO granted patent. Top assignee: Cold Spring Harbor Laboratory. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015
Title: Aftabul Haque: Innovator in PTP1B Inhibitors
Introduction
Aftabul Haque is a notable inventor based in Stony Brook, NY (US). He has made significant contributions to the field of biochemistry, particularly in the development of PTP1B inhibitors. His work focuses on innovative agents that have the potential to impact therapeutic strategies.
Latest Patents
Aftabul Haque holds a patent for PTP1B inhibitors. This patent describes agents, including antibodies, antibody fragments, polypeptides, and organic small molecules, that bind reversibly to inactive PTP1B. These agents stabilize PTP1B-OX in a manner that inhibits the reactivation of reversibly oxidized, inactive PTP1B by reduction. Importantly, they do not have a substantial direct inhibitory effect on phosphatase activity.
Career Highlights
Aftabul Haque is affiliated with Cold Spring Harbor Laboratory, where he conducts his research. His work has garnered attention for its potential applications in treating various diseases related to PTP1B activity.
Collaborations
Aftabul Haque collaborates with Nicholas K Tonks, a fellow researcher in the field. Their partnership enhances the research efforts at Cold Spring Harbor Laboratory.
Conclusion
Aftabul Haque's innovative work on PTP1B inhibitors showcases his commitment to advancing biochemistry and therapeutic development. His contributions are paving the way for future research and potential medical breakthroughs.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile